{
  "actions": [
    {
      "acted_at": "2010-09-29",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2010-09-29",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr6331-111",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "111",
  "cosponsors": [
    {
      "bioguide_id": "D000197",
      "district": "1",
      "name": "DeGette, Diana",
      "original_cosponsor": true,
      "sponsored_at": "2010-09-29",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "G000410",
      "district": "29",
      "name": "Green, Gene",
      "original_cosponsor": true,
      "sponsored_at": "2010-09-29",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000572",
      "district": "8",
      "name": "Rogers, Mike J.",
      "original_cosponsor": true,
      "sponsored_at": "2010-09-29",
      "state": "MI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000413",
      "district": "1",
      "name": "Whitfield, Ed",
      "original_cosponsor": true,
      "sponsored_at": "2010-09-29",
      "state": "KY",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2010-09-29",
  "number": "6331",
  "official_title": "To provide incentives for the development of qualified infectious disease products.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Generating Antibiotic Incentives Now Act of 2010",
  "sponsor": {
    "bioguide_id": "G000550",
    "district": "11",
    "name": "Gingrey, Phil",
    "state": "GA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2010-09-29",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Food and Drug Administration (FDA)",
    "Health",
    "Infectious and parasitic diseases",
    "Intellectual property",
    "Medical research",
    "Medical tests and diagnostic methods",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2010-09-29",
    "date": "2011-01-26T14:55:36Z",
    "text": "Generating Antibiotic Incentives Now Act of 2010 - Amends the Federal Food, Drug, and Cosmetic Act to: (1) extend for five years\u00a0the exclusivity period for the first licensure of a\u00a0qualified infectious disease product; (2)\u00a0grant priority review\u00a0to\u00a0an application for approval or licensure\u00a0of\u00a0a\u00a0qualified infectious disease product (i.e., review and action on\u00a0such application not later than six months after receipt); and (3) deem a qualified infectious disease product as a fast track product, for review and approval purposes.\u00a0 Defines \"qualified infectious disease product\" as an antibiotic drug, or a diagnostic test including a point-of-care diagnostic test, for treating, detecting, preventing, or identifying a qualifying pathogen.\u00a0\n\nRequires the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs, to review the guidelines of the Food and Drug Administration (FDA) for the conduct of clinical trials for antibiotic drugs and revise such guidelines to reflect developments in medical information and technology.\u00a0 Allows the sponsor of a drug intended to be used to treat, detect, prevent, or identify a qualifying pathogen, as defined by this Act,\u00a0to request that the Secretary provide written recommendations for nonclinical and clinical investigations before such drug may be approved for use or licensed."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generating Antibiotic Incentives Now Act of 2010",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To provide incentives for the development of qualified infectious disease products.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generating Antibiotic Incentives Now Act of 2010",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:21:30Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/111/hr/BILLSTATUS-111hr6331.xml"
}